COVID 19: Diabetes and Obesity API-ICP Recommendations

• Published in: Journal of the Association of Physicians of India Vol. 68; no. 5; p. 42
• Main Authors: Joshi, Shashank R, Tiwaskar, Mangesh H, Shah, Siddharth N
• Format: Journal Article
• Language: English
• Published: India 01.05.2020
• Subjects: Betacoronavirus; Blood Glucose - analysis; Coronavirus Infections - complications; COVID-19; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - drug therapy; Humans; Hypoglycemic Agents - therapeutic use; Insulin - therapeutic use; Obesity - complications; Pandemics; Pneumonia, Viral - complications; Risk Factors; SARS-CoV-2

Diabetes and Obesity are major risk factors which confer vulnerability to Covid 19 . Diabetes has immune defects which makes the individual susceptible to infections and covid 19 is no exception . Also covid 19 can cause pancreatic damage as well as stress hyperglycaemia in hospitals which may need...